Immunization News and Research

RSS

Study indicates possibility of a vaccine to prevent Group B Streptococcus infection

Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have completed a Phase II clinical study that indicates a vaccine to prevent Group B Streptococcus (GBS) infection is possible. GBS is the most common cause of sepsis and meningitis in newborns in the United States, according to the Centers for Disease Control and Prevention (CDC). It can also cause severe illness in pregnant women, the elderly and adults with chronic illnesses.

31 Oct 2009

Public concern can undermine flu vaccination campaigns

The effectiveness of pandemic flu vaccination campaigns - like that now underway for H1N1 - could be undermined by the public incorrectly associating coincidental and unrelated health events with the vaccines.

31 Oct 2009

Health officials stress the need for continued prevention efforts in view of H1N1 vaccine delay

Responding to delays in the nationwide distribution H1N1 flu vaccine, Department of Health officials today urged Pennsylvanians to continue to take steps to prevent the spread of illness.

30 Oct 2009

Mollen Immunization Clinics sets US record for administering 14,000 vaccinations in a single event

With just 36 hours notice from the Maricopa County Department of Public Health, Mollen Immunization Clinics administered over 14,000 vaccinations to high-risk groups throughout the county, one of the nation's largest with a population of four million residents.

30 Oct 2009

Patients on immunosuppressant medication can receive H1N1 vaccine in the form of shots

The Centers for Disease Control and Prevention (CDC) have classified all children, 6-months to 24-years, one of the high risk groups for contracting the H1N1 (swine) flu, and recommend this population receive the H1N1 vaccine for immunity against the disease.

30 Oct 2009

Studies demonstrate that investigational cancer vaccines show encouraging immune response rates

Results of two phase 1 studies demonstrate that the novel, investigational cancer vaccines MKC1106-MT and MKC1106-PP are well-tolerated and show encouraging immune response rates and objective tumor response in advanced melanoma, prostate cancer and other solid malignancies, setting the stage for phase 2 studies.

30 Oct 2009

Dynavax Technologies announces first clinical data for HEPLISAV investigational hepatitis B vaccine

Dynavax Technologies Corporation today announced the first clinical data for HEPLISAVTM investigational hepatitis B vaccine in chronic kidney disease patients.

30 Oct 2009

New online education course on H1N1 vaccination now available

mdBriefCase Inc., in collaboration with the Public Health Agency of Canada (PHAC), is pleased to provide a new online education course on H1N1 vaccination for health professionals.

30 Oct 2009

New campaign offers information and resources on seasonal and H1N1 flu prevention

Blue Cross Blue Shield of Arizona (BCBSAZ) says “Get the facts, not the flu,” in a new campaign that launches today at azblue.com/Flu. The flu campaign offers its members, employer groups and Arizona residents information and resources on seasonal and H1N1 flu prevention and immunization.

30 Oct 2009

Gates Foundation praises U.S. global health investments, calls for 15-year goal of cutting child deaths worldwide by nearly half

As part of a "major push to convince the United States to maintain government spending on worldwide health initiatives, despite the financial crisis and a soaring U.S. budget deficit," the Bill & Melinda Gates Foundation is urging U.S. policymakers to commit to cutting "the number of child deaths each year, from 9 million to 5 million" by 2025, CNN reports (Evans, 10/28).

28 Oct 2009

Dementia patients face higher risk of flu mortality; refine guidelines needed for testing and vaccination policies

An epidemiological study on pneumonia and influenza (P&I) in adults age 65 and over reports that patients with dementia are diagnosed with flu less frequently, have shorter hospital stays, and have a fifty percent higher rate of death than those without dementia.

28 Oct 2009

H1N1 overwhelms hospitals; Sebelius addresses flu vaccine shortage

Hospitals across the country are overwhelmed "as waves of flu patients arrive at their doors, doubling their emergency room volume," USA Today reports. "Just as significant is the effect on intensive care units: A relatively small number of flu patients are requiring intensive care, but some are so ill they will need round-the-clock care for weeks.

27 Oct 2009

ImmunoCellular Therapeutics presents additional data from its ICT-107 Phase I clinical trial

ImmunoCellular Therapeutics, Ltd., a biotechnology company that is focused on the development of novel immune-based cancer therapies, today announced additional data from its Phase I clinical trial evaluating ICT-107, the Company’s dendritic-cell based cancer vaccine product candidate for the treatment of glioblastoma multiforme (GBM).

27 Oct 2009

Boston Medical Center deploys Fusionfx Immunization Management portal to manage H1N1 vaccination

Acknowledging the critical role of Centers for Disease Control and Prevention (CDC) guidelines in ensuring the safety and efficacy of H1N1 vaccinations, Carefx Corporation, a leading provider of interoperable workflow solutions to advance the quality and safety of patient care, today announced that Boston Medical Center (BMC) has deployed the Fusionfx Immunization Management portal designed to enter and track H1N1 vaccination administration history and support broad, community-wide immunization administration tracking.

27 Oct 2009

AJPM article calls for increased effectiveness research on clinical preventive services for adolescents

Too little attention is paid to improving the delivery of clinical preventive services to adolescents by addressing problems unique to that population, says a new study commissioned by Partnership for Prevention.

27 Oct 2009

Vaccination rates need improvement; racial and ethnic disparities in vaccination coverage

More teenagers are being vaccinated against human papillomavirus (HPV), meningococcal meningitis and pertussis (whooping cough), though the rates are still too low, according to recently released government data and a panel of experts convened by the National Foundation for Infectious Diseases (NFID).

27 Oct 2009

ImmunoCellular Therapeutics to present Phase I clinical trial data of ICT-107 vaccine in New Orleans

ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune-based therapies for the treatment of brain and other cancers, today announced that it will be presenting today, at the Annual Meeting of the Congress of Neurological Surgeons in New Orleans, Louisiana at 3:15pm central time, data from its Phase I clinical trial investigating the role that its ICT-107 vaccine may play in increasing patient survival and inhibiting tumor progression in patients with glioblastoma, the most common and most aggressive type of primary brain tumor.

26 Oct 2009

Maxim Health Systems cancels all flu shot clinics at retail locations

Maxim Health Systems has cancelled all flu shot clinics at retail locations after October 22, due to lack of vaccine availability. Across the country, there has been a drastic increase in both demand and media attention regarding influenza and vaccine availability. While the nation is experiencing an increase in demand for flu vaccine, manufacturers are unable to produce more seasonal flu vaccine because all resources have been shifted to H1N1 production.

24 Oct 2009

Pregnant women unsure about getting H1N1 flu shot, shows new survey

Despite majorities expressing concern about getting the novel H1N1 (or swine) flu this year, only about one in four pregnant women or new mothers plan to get the H1N1 flu shot, according to findings from a new survey conducted on behalf of HealthyWomen by Harris Interactive.

24 Oct 2009

Recent releases in Global Health

"The spread of dengue virus throughout the tropics represents a major, rapidly growing public health problem with an estimated 2.5 billion people at risk of dengue fever and the life-threatening disease, severe dengue," write the authors of a Lancet Infectious Diseases review that examines what is known about the virus and progress in the development of a dengue vaccine (Webster et. al, 11/09).

24 Oct 2009

Immunization News and Research

Study indicates possibility of a vaccine to prevent Group B Streptococcus infection

Public concern can undermine flu vaccination campaigns

Health officials stress the need for continued prevention efforts in view of H1N1 vaccine delay

Mollen Immunization Clinics sets US record for administering 14,000 vaccinations in a single event

Patients on immunosuppressant medication can receive H1N1 vaccine in the form of shots

Studies demonstrate that investigational cancer vaccines show encouraging immune response rates

Dynavax Technologies announces first clinical data for HEPLISAV investigational hepatitis B vaccine

New online education course on H1N1 vaccination now available

New campaign offers information and resources on seasonal and H1N1 flu prevention

Gates Foundation praises U.S. global health investments, calls for 15-year goal of cutting child deaths worldwide by nearly half

Dementia patients face higher risk of flu mortality; refine guidelines needed for testing and vaccination policies

H1N1 overwhelms hospitals; Sebelius addresses flu vaccine shortage

ImmunoCellular Therapeutics presents additional data from its ICT-107 Phase I clinical trial

Boston Medical Center deploys Fusionfx Immunization Management portal to manage H1N1 vaccination

AJPM article calls for increased effectiveness research on clinical preventive services for adolescents

Vaccination rates need improvement; racial and ethnic disparities in vaccination coverage

ImmunoCellular Therapeutics to present Phase I clinical trial data of ICT-107 vaccine in New Orleans

Maxim Health Systems cancels all flu shot clinics at retail locations

Pregnant women unsure about getting H1N1 flu shot, shows new survey

Recent releases in Global Health

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News